TB Breath Test Proposal: Difference between revisions
(20.109 Research Proposal Pink WF) |
No edit summary |
||
| Line 1: | Line 1: | ||
20.109 WF Pink Team Research Proposal | |||
TB Breath Test | |||
'''Project Overview:''' | |||
'''Background''' | |||
''-Disease background'' | |||
-Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis | |||
-can be fatal | |||
-usually affects the lungs, but can also affect brain, kidneys, spine | |||
-symptoms include weight loss, night sweats, fever, chills, coughing (blood), chest pain | |||
-latent vs active infection | |||
-becomes active if immune system cannot repress growth | |||
-5-10% of latent cases will become active | |||
''-2 widely used current tests:'' | |||
-Mantoux TB skin test injects a small amount of tuberculin into the skin | |||
-patient must return to clinic 48/72 hours later for evaluation of injection site | |||
-TB blood test (interferon-gamma release assay) measures immune system reaction to TB bacteria | |||
'''Problem/Goals Statement:''' | |||
'''Details/Method:''' | |||
''' | |||
Predicted Outcomes:''' | |||
'''Resources:''' | |||
Revision as of 19:38, 3 December 2013
20.109 WF Pink Team Research Proposal
TB Breath Test
Project Overview:
Background -Disease background -Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis -can be fatal -usually affects the lungs, but can also affect brain, kidneys, spine -symptoms include weight loss, night sweats, fever, chills, coughing (blood), chest pain -latent vs active infection -becomes active if immune system cannot repress growth -5-10% of latent cases will become active
-2 widely used current tests: -Mantoux TB skin test injects a small amount of tuberculin into the skin -patient must return to clinic 48/72 hours later for evaluation of injection site -TB blood test (interferon-gamma release assay) measures immune system reaction to TB bacteria
Problem/Goals Statement:
Details/Method:
Predicted Outcomes:
Resources:
